ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

OCC to Take Over CIS Oct; Cost Sharing “Is Dead”

July 15, 1988

In Brief: Fredrickson Okays NCI Reorganization, Plan At Hew; Miller Leave International Affairs Job

February 8, 1980

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976